CMS Awards Monteris Add-On Payment For Tumor Ablation Catheter

Monteris Medical expects to deploy its AutoLITT tumor ablation catheter to the market "slowly and methodically" following a favorable Medicare reimbursement decision, according to Jim Duncan, the firm's CEO

More from Archive

More from Medtech Insight